Literature DB >> 35995311

A distinct phylogenetic cluster of Monkeypox genomes suggests an early and cryptic spread of the virus.

Bani Jolly1, Vinod Scaria2.   

Abstract

Entities:  

Keywords:  2022 Outbreak; Lineage A.2; Lineage B.1; Monkeypox

Year:  2022        PMID: 35995311      PMCID: PMC9528192          DOI: 10.1016/j.jinf.2022.08.013

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   38.637


× No keyword cloud information.
To the Editor Orviz et al. recently described the outbreak of monkeypox in Spain, which is part of a larger European outbreak, in this journal. The outbreak has been epidemiologically linked to potential superspreader events in Europe earlier in the year 2022 and over a short period has spread across 75 countries causing over 20,000 infections as on 30 July 2022, with the World Health Organization subsequently declaring the outbreak as a public health emergency of international concern in July 2022. Following the outbreak, the wide availability of monkeypox genome sequences in the public domain provided a unique opportunity to understand the genetic epidemiology as well as the evolution of the pathogen. With heightened surveillance and molecular diagnosis across the globe, several genomes of the monkeypox virus are being deposited in public databases like GISAID. As early epidemiologic studies linked the outbreak of monkeypox in 2022 to superspreader event(s) in Europe, it was therefore not surprising that a majority of the genomes available on GISAID cluster together (clade IIb). Further reports suggest that the early transmission in this outbreak was largely amongst gays, bisexuals and other men who have sex with men (MSM) with some exceptions. , However, the recently deposited genome sequences from the United States of America, Thailand and much more recently from India suggest a distinctly different phylogenetic cluster of genomes within clade IIb, classified by Nextclade as lineage A.2, in contrast to the cluster encompassing the majority of genomes (N = 547) that are classified as lineage B.1 (Fig. 1 A). , , The A.2 lineage comprises 9 genomes from 6 unique clinical isolates, with the earliest genome belonging to this lineage (collected in July 2021) being deposited from the state of Texas, USA. The two genome isolates from India cluster closely with a genome isolate from Florida (hMpxV/USA/FL-DHCPPCDC-001/2022) on the phylogenetic tree, while the isolates from Texas, Virginia and Thailand mapped to separate sub-clusters (Fig. 1B).
Fig. 1

(A) Phylogenetic tree of genome isolates from GISAID belonging to the hMPXV-1 clade of monkeypox virus constructed using Nextstrain. (B) Phylogenetic tree of the genomes belonging to A.2 monkeypox lineage. (C) Comparison of frequencies of variations present in >90% genomes of lineages A.2 (N = 6) and B.1 (N = 547).

(A) Phylogenetic tree of genome isolates from GISAID belonging to the hMPXV-1 clade of monkeypox virus constructed using Nextstrain. (B) Phylogenetic tree of the genomes belonging to A.2 monkeypox lineage. (C) Comparison of frequencies of variations present in >90% genomes of lineages A.2 (N = 6) and B.1 (N = 547). The genomes belonging to the A.2 lineage have 16 distinct genetic variations which are not found in other lineages, of which 9 are nonsynonymous, 3 are synonymous and 1 is a stopgain variation, along with a deletion of 3-amino acid deletion in the gene OPG174 (Fig. 1C). Variants found at a minimum frequency of 90% in the respective lineages A.2 and B.1 were compared and are summarised in Fig. 1C. Albeit the limited number of sequences available for the A.2 lineage, we attempted to compute the time to the most recent common ancestor (tMRCA) for A.2 and the nucleotide substitution rates for lineages A.2 and B.1 using BEAST v1.10.4. The tMRCA was calculated following a coalescent growth rate model with a strict molecular clock and the HKY+Γ substitution model. MCMC was run for 50 million steps and the initial 1% steps were discarded as burn-in. The tMRCA of the A.2 lineage was computed as 25 June 2021 (95% HPD 19 March 2021 to 1 July 2021). The A.2 lineage had a mean nucleotide substitution rate of 5.53 × 10−5 (95% HPD 3.39 × 10−5 to 7.46 × 10−5) substitutions per base/year, suggesting a modest rate of substitution compared to the substitution rate of 1.13 × 10−4 (95% HPD 9.33 × 10−5 to 1.33 × 10−4) substitutions per base/year for the larger B.1 lineage of genomes. Accelerated evolution of the B.1 lineage has been observed recently. Limited demographic information could be linked to the members of the A.2 cluster and has been primarily compiled from the metadata associated with the genome sequences as well as reports in the public domain. The two genomes from Kerala, India were isolated from men who had a travel history to the United Arab Emirates, while the genome from Thailand was isolated from a male traveller from Nigeria. The genome from Texas, United States of America, the earliest in the cluster, was also isolated from a male traveller from Nigeria suggesting a wider geographic area with ongoing transmission of the virus beyond regions in Central and Eastern Africa where the virus is endemic. Put together, the evidence suggests that this unique and distinct phylogenetic cluster of genomes, therefore, represents sustained and previously uncharacterized human-human transmission events spanning multiple countries. The tMRCA dating to mid-2021 and the earliest genome dating to July 2021 suggests that this sustained transmission event possibly preceded the outbreak in 2022 in Europe and has remained largely undetected. The distinct genomic signatures suggest that this transmission chain may not be linked to the large outbreak of monkeypox which occurred in 2022 and has been potentially uncovered due to heightened awareness, surveillance and the wider availability of diagnostics. This report, therefore, re-affirms the unique and significant value of genomic surveillance of emerging pathogens in uncovering potential new insights and leads for epidemiological investigations. The distinctive finding in this report may have a significant impact on public health policies, surveillance as well as public-health communication.

Funding

This work was supported by the Council of Scientific and Industrial Research (CSIR), India. The funders had no role in the analysis of data, preparation of the manuscript or decision to publish.

Declaration of Competing Interest

The authors report no potential conflicts of interest.
  7 in total

1.  Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022.

Authors:  John P Thornhill; Sapha Barkati; Sharon Walmsley; Juergen Rockstroh; Andrea Antinori; Luke B Harrison; Romain Palich; Achyuta Nori; Iain Reeves; Maximillian S Habibi; Vanessa Apea; Christoph Boesecke; Linos Vandekerckhove; Michal Yakubovsky; Elena Sendagorta; Jose L Blanco; Eric Florence; Davide Moschese; Fernando M Maltez; Abraham Goorhuis; Valerie Pourcher; Pascal Migaud; Sebastian Noe; Claire Pintado; Fabrizio Maggi; Ann-Brit E Hansen; Christian Hoffmann; Jezer I Lezama; Cristina Mussini; AnnaMaria Cattelan; Keletso Makofane; Darrell Tan; Silvia Nozza; Johannes Nemeth; Marina B Klein; Chloe M Orkin
Journal:  N Engl J Med       Date:  2022-07-21       Impact factor: 176.079

2.  GISAID: Global initiative on sharing all influenza data - from vision to reality.

Authors:  Yuelong Shu; John McCauley
Journal:  Euro Surveill       Date:  2017-03-30

3.  Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10.

Authors:  Marc A Suchard; Philippe Lemey; Guy Baele; Daniel L Ayres; Alexei J Drummond; Andrew Rambaut
Journal:  Virus Evol       Date:  2018-06-08

4.  Nextstrain: real-time tracking of pathogen evolution.

Authors:  James Hadfield; Colin Megill; Sidney M Bell; John Huddleston; Barney Potter; Charlton Callender; Pavel Sagulenko; Trevor Bedford; Richard A Neher
Journal:  Bioinformatics       Date:  2018-12-01       Impact factor: 6.931

5.  Monkeypox in a Traveler Returning from Nigeria - Dallas, Texas, July 2021.

Authors:  Agam K Rao; Joann Schulte; Tai-Ho Chen; Christine M Hughes; Whitni Davidson; Justin M Neff; Mary Markarian; Kristin C Delea; Suzanne Wada; Allison Liddell; Shane Alexander; Brittany Sunshine; Philip Huang; Heidi Threadgill Honza; Araceli Rey; Benjamin Monroe; Jeffrey Doty; Bryan Christensen; Lisa Delaney; Joel Massey; Michelle Waltenburg; Caroline A Schrodt; David Kuhar; Panayampalli S Satheshkumar; Ashley Kondas; Yu Li; Kimberly Wilkins; Kylie M Sage; Yon Yu; Patricia Yu; Amanda Feldpausch; Jennifer McQuiston; Inger K Damon; Andrea M McCollum
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2022-04-08       Impact factor: 35.301

6.  Urgent need for a non-discriminatory and non-stigmatizing nomenclature for monkeypox virus.

Authors:  Christian Happi; Ifedayo Adetifa; Placide Mbala; Richard Njouom; Emmanuel Nakoune; Anise Happi; Nnaemeka Ndodo; Oyeronke Ayansola; Gerald Mboowa; Trevor Bedford; Richard A Neher; Cornelius Roemer; Emma Hodcroft; Houriiyah Tegally; Áine O'Toole; Andrew Rambaut; Oliver Pybus; Moritz U G Kraemer; Eduan Wilkinson; Joana Isidro; Vítor Borges; Miguel Pinto; João Paulo Gomes; Lucas Freitas; Paola C Resende; Raphael T C Lee; Sebastian Maurer-Stroh; Cheryl Baxter; Richard Lessells; Ahmed E Ogwell; Yenew Kebede; Sofonias K Tessema; Tulio de Oliveira
Journal:  PLoS Biol       Date:  2022-08-23       Impact factor: 9.593

7.  Monkeypox outbreak in Madrid (Spain): Clinical and virological aspects.

Authors:  Eva Orviz; Anabel Negredo; Oskar Ayerdi; Ana Vázquez; Ana Muñoz-Gomez; Sara Monzón; Petunia Clavo; Angel Zaballos; Mar Vera; Patricia Sánchez; Noemi Cabello; Pilar Jiménez; Jorge A Pérez-García; Sarai Varona; Jorge Del Romero; Isabel Cuesta; Alberto Delgado-Iribarren; Montse Torres; Iñigo Sagastagoitia; Gustavo Palacios; Vicente Estrada; Maria Paz Sánchez-Seco
Journal:  J Infect       Date:  2022-07-10       Impact factor: 38.637

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.